Similarly, inhibition of downstream DDR kinases, such as checkpoint kinase 1 (CHK1), potentiated the anti-cancer activities of chemotherapeutic agents [40], thereby illustrating that targeting of deregulated DDR proteins might be an effective strategy to reverse cancer drug resistance. Here, CHEK1 is linked to cancer.